Skip to main content

Certolizumab pegol has a different profile from other anti-TNFs, including golimumab, in a variety of in vitro assays

Access & Citations

  • 1407
    Article Accesses
  • 0
    Web of Science
  • 1
    CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.